04/29/2024 3:16 PM | Intellia Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024 3:10 PM | Dube Michael P (Reporting) Intellia Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/15/2024 3:21 PM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/22/2024 8:26 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/26/2024 6:04 AM | Intellia Therapeutics (Filer)
| Form 424B5 | |
02/23/2024 4:22 PM | Intellia Therapeutics (Filer)
| Form 424B5 | |
02/23/2024 4:17 PM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
02/22/2024 6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/29/2024 3:00 PM | ARK Investment Management LLC (Filed by) Intellia Therapeutics (Subject)
| Form SC 13G/A | |
01/24/2024 10:21 AM | Intellia Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/10/2024 3:15 PM | Intellia Therapeutics (Issuer) Sepp-Lorenzino Laura (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:35 PM | BlackRock Inc. (Filed by) Intellia Therapeutics (Subject)
| Form SC 13G/A | |
01/05/2024 3:44 PM | Clark Eliana (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:45 PM | BASTA JAMES (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:46 PM | Hicks Derek (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:49 PM | Goddard Glenn (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:50 PM | Intellia Therapeutics (Issuer) Sepp-Lorenzino Laura (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:50 PM | Intellia Therapeutics (Issuer) Lebwohl David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:51 PM | Intellia Therapeutics (Issuer) LEONARD JOHN M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:07 PM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2024 4:28 PM | Goddard Glenn (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 4:30 PM | Intellia Therapeutics (Issuer) LEONARD JOHN M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 4:34 PM | Intellia Therapeutics (Issuer) Lebwohl David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 4:35 PM | Intellia Therapeutics (Issuer) Sepp-Lorenzino Laura (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 7:09 PM | Crowley John F (Reporting) Intellia Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023 6:00 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/24/2023 8:30 AM | Intellia Therapeutics (Filer)
| Form S-3ASR | |
11/09/2023 6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 3:42 PM | Bhanji Muna (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2023 6:11 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/18/2023 6:30 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2023 6:19 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/03/2023 3:13 PM | Intellia Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023 6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/02/2023 4:19 PM | Bhanji Muna (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2023 3:45 PM | Bhanji Muna (Reporting) Intellia Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2023 4:21 PM | Bhanji Muna (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 3:22 PM | Bhanji Muna (Reporting) Intellia Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/06/2023 2:34 PM | Clark Eliana (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2023 4:52 PM | Clark Eliana (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 6:39 PM | Clark Eliana (Reporting) Intellia Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
The asset beating inflation by 4x (Ad) "Trump Loophole" Beats Inflation?
Inflation has been out of control for years.
Forcing you to work longer and harder for more money that is worth less.
By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties. That's why we have released our Free Precious Metals Investment Guide that explains all the details |
06/16/2023 3:24 PM | Bhanji Muna (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 3:26 PM | Cohen Fred E (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 3:13 PM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/12/2023 6:00 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2023 3:52 PM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |